Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement

The purpose of this guideline is to present evidence-based consensus recommendations for low dose rate (LDR) permanent seed brachytherapy for the primary treatment of prostate cancer.

Source: Brachytherapy - September 8, 2021 Category: Cancer & Oncology Authors: Martin T. King, Mira Keyes, Steven J Frank, Juanita M. Crook, Wayne M. Butler, Peter J. Rossi, Brett W. Cox, Timothy N. Showalter, Firas Mourtada, Louis Potters, Richard G. Stock, Marisa A. Kollmeier, Michael J. Zelefsky, Brian J. Davis, Gregory S. Merric Source Type: research